Investigating the Association of ApoE Genotypes with Blood-Brain Barrier Dysfunction Measured by Cerebrospinal Fluid-Serum Albumin Ratio in a Cohort of Patients with Different Types of Dementia

被引：18
作者：
Karch, Andre [1 ,2 ]
Manthey, Henrike [1 ]
Ponto, Claudia [1 ]
Hermann, Peter [1 ]
Heinemann, Uta [1 ]
Schmidt, Christian [1 ]
Zerr, Inga [1 ]
机构：
[1] Univ Hosp Gottingen, Clin Dementia Ctr, Dept Neurol, Gottingen, Germany
[2] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany
来源：
PLOS ONE | 2013年 / 8卷 / 12期
关键词：
ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; PERMEABILITY; CRITERIA;
D O I：
10.1371/journal.pone.0084405
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Background: Since more than a decade ApoE is known to be a strong risk factor for Alzheimer's disease (AD); however, molecular pathways mediating this risk are still unclear. In recent years it has been hypothesized that ApoE might play a role in the disintegration of blood-brain barrier (BBB). In the present study we addressed the question if ApoE genotypes might be associated with BBB function measured by albumin ratio (Q(Alb)) in a large cohort of patients with different types of dementia. Methods: Five hundred twenty (520) patients with Creutzfeldt-Jakob disease (CJD, n = 350), Alzheimer's disease (n = 71) and cerebral small vessel disease (n = 99) were assessed for their ApoE genotype. BBB function was measured in all patients using Q(Alb) and was compared between ApoE genotypes. Dominant and additive genetic models were assumed in order to investigate the potential effect of ApoE on BBB function. Results: We observed no systematic differences in Q(Alb) between ApoE genotypes within the present study. Increased Q(Alb) levels were shown for those without E3 allele in the subgroup of CJD patients when assuming a dominant genetic model (p = 0.035). This could not be confirmed for patients with other forms of dementia (p = 0.234). Discussion: Although there was some evidence for a protective effect of E3 alleles in CJD patients, this study does not support the hypothesis of a systematic role of ApoE genotypes in BBB function in individuals with a diagnosis of dementia. Thus, changes in BBB function do not seem to contribute to the increased risk of cognitive decline associated with certain ApoE genotypes. The interpretation of the results of this study must take into account that BBB function was only assessed by measuring Q(Alb) which has been shown to be a good marker for overall BBB integrity but might not reflect all qualities of the barrier.
引用
收藏
页数：6
相关论文
共 27 条
  • [11] Blood-brain barrier: Ageing and microvascular disease-systematic review and meta-analysis
    Farrall, Andrew J.
    Wardlaw, Joanna M.
    [J]. NEUROBIOLOGY OF AGING, 2009, 30 (03) : 337 - 352
  • [12] APOE and Alzheimer disease: a major gene with semi-dominant inheritance
    Genin, E.
    Hannequin, D.
    Wallon, D.
    Sleegers, K.
    Hiltunen, M.
    Combarros, O.
    Bullido, M. J.
    Engelborghs, S.
    De Deyn, P.
    Berr, C.
    Pasquier, F.
    Dubois, B.
    Tognoni, G.
    Fievet, N.
    Brouwers, N.
    Bettens, K.
    Arosio, B.
    Coto, E.
    Del Zompo, M.
    Mateo, I.
    Epelbaum, J.
    Frank-Garcia, A.
    Helisalmi, S.
    Porcellini, E.
    Pilotto, A.
    Forti, P.
    Ferri, R.
    Scarpini, E.
    Siciliano, G.
    Solfrizzi, V.
    Sorbi, S.
    Spalletta, G.
    Valdivieso, F.
    Vepsalainen, S.
    Alvarez, V.
    Bosco, P.
    Mancuso, M.
    Panza, F.
    Nacmias, B.
    Bossu, P.
    Hanon, O.
    Piccardi, P.
    Annoni, G.
    Seripa, D.
    Galimberti, D.
    Licastro, F.
    Soininen, H.
    Dartigues, J-F
    Kamboh, M. I.
    Van Broeckhoven, C.
    [J]. MOLECULAR PSYCHIATRY, 2011, 16 (09) : 903 - 907
  • [13] The Association of APOE Genotype with Cognitive Function in Persons Aged 35 Years or Older
    Izaks, Gerbrand J.
    Gansevoort, Ron T.
    van der Knaap, Aafke M.
    Navis, Gerjan
    Dullaart, Robin P. F.
    Slaets, Joris P. J.
    [J]. PLOS ONE, 2011, 6 (11):
  • [14] Kolovou GD, 2005, ANN CLIN LAB SCI, V35, P391
  • [15] Genetic association studies
    Lunetta, Kathryn L.
    [J]. CIRCULATION, 2008, 118 (01) : 96 - 101
  • [16] Total tau protein, phosphorylated tau (181p) protein, β-amyloid1-42, and β-amyloid1-40 in cerebrospinal fluid of patients with dementia with Lewy bodies
    Mollenhauer, B
    Bibl, M
    Wiltfang, J
    Steinacker, P
    Ciesielczyk, B
    Neubert, K
    Trenkwalder, C
    Otto, M
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) : 192 - 195
  • [17] Cardiopulmonary Bypass Increases Permeability of the Blood-Cerebrospinal Fluid Barrier
    Okamura, Toru
    Ishibashi, Nobuyuki
    Zurakowski, David
    Jonas, Richard A.
    [J]. ANNALS OF THORACIC SURGERY, 2010, 89 (01) : 187 - 194
  • [18] In search of genes involved in neurodegenerative disorders
    Pardo, LM
    van Duijn, CM
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2005, 592 (1-2) : 89 - 101
  • [19] Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease
    Pisani, Valerio
    Stefani, Alessandro
    Pierantozzi, Mariangela
    Natoli, Silvia
    Stanzione, Paolo
    Franciotta, Diego
    Pisani, Antonio
    [J]. JOURNAL OF NEUROINFLAMMATION, 2012, 9
  • [20] Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79
123